Physician profile
Kyle Lewis
NPI 1902017924
$63,820.40
in general payments reported to CMS, 2019-2025
9 companies · $8,220 in 2025
The $8,220 reported for 2025 was more than what 89% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $7,769 · 2023: $40K · 2024: $7,737 · 2025: $8,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,188 · Consulting Fee: $5,250 · Travel and Lodging: $4,869 · Food and Beverage: $2,010 · Education: $10.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $34,725.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,187.50 |
| Consulting Fee | $5,250.00 |
| Travel and Lodging | $4,869.34 |
| Food and Beverage | $2,010.04 |
| Education | $10.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $47,793.85 | 2022-2023 | Tepezza |
| Amgen INC. | $15,673.74 | 2024-2025 | Tepezza |
| Glaukos Corporation | $139.14 | 2025 | Photrexa Viscous and Photrexa |
| Johnson & Johnson Surgical Vision, INC. | $90.67 | 2025 | Tecnis Simplicity |
| Inspire Medical Systems, INC. | $69.46 | 2023 | Inspire |
| Thea Pharma INC. | $22.26 | 2025 | Iyuzeh |
| Sight Sciences, INC. | $15.64 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $15.64 | 2025 | Acthar |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.